Research Article
Cardiometabolic Risk in Hyperlipidemic Men and Women
Table 1
Characteristics of the study sample, divided by sex.
| | (female/male) | Female | Male | value |
| Age [years] | 35/64 | | | 0.001 | BMI [kg/m2] | 34/61 | | | 0.998 | Body weight | 34/61 | | | <0.001 | Waist [cm] | 31/58 | | | 0.011 | RRS [mmHg] | 24/45 | | | 0.089 | RRD [mmHg] | 24/45 | | | 0.162 | TC [mg/dL] | 35/64 | | | 0.290 | LDL-C [mg/dL] | 34/60 | | | 0.174 | LDL-C < 100 mg/dL | 34/60 | 9 (26.5%) | 17 (28.3%) | 0.911 | HDL-C [mg/dL] | 33/60 | | | <0.001 | NHDL-C [mg/dL] | 33/60 | | | 0.947 | ln(TG) [mg/dL] | 35/64 | | | 0.008 | ln(TG/HDL) | 33/60 | | | <0.001 | ln(Lip.a) [units] | 30/57 | | | 0.031 | IMT-left [mm] | 31/58 | | | 0.584 | IMT-right [mm] | 30/56 | | | 0.824 | IMT av [mm] | 30/56 | | | 0.711 | Glucose [mg/dL] | 34/61 | | | 0.720 | ln(insulin+1) [μU/mL] | 32/60 | | | 0.131 | C-peptide [ng/mL] | 28/50 | | | 0.546 | HbA1c [%] | 35/62 | | | 0.054 | QUICKI-test | 29/49 | | | 0.266 | ln(proBNP) [units] | 30/55 | | | <0.001 | ln(hsCRP+1) [units] | 30/62 | | | 0.161 | ln(GOT) [mg/dL] | 34/64 | | | 0.263 | ln(GPT) [mg/dL] | 34/64 | | | 0.021 | ln(GGT) [mg/dL] | 34/64 | | | 0.003 | Prediabetes | 34/62 | 19 (55.9) | 29 (46.8) | 0.522 | Ezetimibe | 33/55 | 3 (9.1) | 6 (10.9) | 1.000 | Nicotinic acid | 33/54 | 1 (3.0) | 4 (7.4) | 0.646 | Fibrates | 33/54 | 5 (15.2) | 22 (40.7) | 0.017 | Statins | 33/54 | 16 (48.5) | 38 (70.4) | 0.068 | CVD | 33/60 | 2 (6.1) | 10 (16.7) | 0.202 | Mean steps 7 days | 31/47 | | | 0.045 | Metabolic syndrome | 21/44 | 7 (33.3) | 16 (36.4) | 1.000 | Mean treatment duration of the last taken dyslipidemic medication (days) | 33/62 | | | 0.721 |
|
|
-test, Chi-square test. Data are presented as number of observations () and means ± standard deviation. BMI (body mass index), waist (waist circumference), RRS (systolic blood pressure), RRD (diastolic blood pressure), TC (total cholesterol), LDL-C (low density lipoprotein cholesterol), HDL-C (high density lipoprotein cholesterol), NHDL-C (non-high density lipoprotein cholesterol), TG (triglycerides), TG/HDL (triglyceride/HDL-cholesterol ratio), Lip.a (lipoprotein (a)), IMT (carotid intima media thickness), HbA1c (glycated hemoglobin A1c), QUICKI (quantitative insulin sensitivity check index), proBNP (pro B-type natriuretic peptide), hsCRP (high sensitive C-reactive protein), GOT (glutamate-oxaloacetate transaminase), GPT (glutamate-pyruvate transaminase), GGT (gamma-glutamyl transferase), and CVD (cardiovascular disease).
|